NOW APPROVED
in Adults with
PRURIGO NODULARIS (PN)
DUPIXENT is a prescription medicine used
to treat adults with prurigo nodularis (PN).
It is not known if DUPIXENT is safe and
effective in children with prurigo nodularis
under 18 years of age.
DUPIXENT can help control a
source of unwanted inflammation
which could be a driver of your PN
Proven results*
~3x as many adults had significantly less itch at 24 weeks
(In trial 1, 60% on DUPIXENT vs 18.4% on placebo; in trial 2, 57.7% on DUPIXENT vs 19.5% on placebo)
Some adults had less itch in as little as 12 weeks
(In trial 2, 37.2% on DUPIXENT vs 22% on placebo)
~3x as many adults had skin that's clear or
almost clear of PN bumps at 24 weeks
(In trial 1, 48% on DUPIXENT vs 18.4% on placebo; in trial 2, 44.9% on DUPIXENT vs 15.9% on placebo)
The most common side effects in patients with prurigo
nodularis include eye and eyelid inflammation, including
redness, swelling, and itching, sometimes with blurred vision,
herpes virus infections, common cold symptoms
(nasopharyngitis), dizziness, muscle pain, and diarrhea.
NOW FDA APPROVED